Evidence map›Paper›PMID 33389473›Full record

ArticleThe protein journal2021

c.1898C>G/p.Ser633Trp Mutation in Alpha-L-Iduronidase: Clinical and Structural Implications.

Iliana Peña-Gomar, José L Jiménez-Mariscal, Magdalena Cerón, Jorge Rosas-Trigueros, Cesar A Reyes-López

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in The protein journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Iliana Peña-GomarHospital Pediátrico Tacubaya, Secretaría de Salud, Ciudad de México, Mexico.
José L Jiménez-MariscalHospital Pediátrico Tacubaya, Secretaría de Salud, Ciudad de México, Mexico.
Magdalena CerónClínica de Enfermedades Lisosomales, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico.
Jorge Rosas-TriguerosLaboratorio Transdisciplinario de Investigación en Sistemas Evolutivos, ESCOM, Instituto Politécnico Nacional, Ciudad de México, Mexico.
Cesar A Reyes-LópezLaboratorio de Bioquímica Estructural, Sección de Estudios de Posgrado E Investigación, ENMyH, SEPI-ENMyH, Instituto Politécnico Nacional., Guillermo Massieu Helguera, No. 239, Fracc. "La Escalera", Ticomán, C.P. 07320, Ciudad de México, Mexico. careyes@ipn.mx.ORCID 0000-0002-9860-8983
Instituto Politécnico Nacional · MXSecretaria de Salud · MXHospital Infantil de México Federico Gómez · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucopolysaccharidosis type I is a rare autosomal recessive genetic disease caused by deficient activity of α-L-iduronidase. As a consequence of low or absent activity of this enzyme, glycosaminoglycans accumulate in the lysosomal compartments of multiple cell types throughout the body. Mucopolysaccharidosis type I has been classified into 3 clinical subtypes, ranging from a severe Hurler form to the more attenuated Hurler-Scheie and Scheie phenotypes. Over 200 gene variants causing the various forms of mucopolysaccharidosis type I have been reported. DNA isolated from dried blood spot was used to sequencing of all exons of the IDUA gene from a patient with a clinical phenotype of severe mucopolysaccharidosis type I syndrome. Enzyme activity of α-L-iduronidase was quantified by fluorimetric assay. Additionally, a molecular dynamics simulation approach was used to determine the effect of the Ser633Trp mutation on the structure and dynamics of the α-L-iduronidase. The DNA sequencing analysis and enzymatic activity shows a c.1898C>G mutation associated a patient with a homozygous state and α-L-iduronidase activity of 0.24 μmol/L/h, respectively. The molecular dynamics simulation analysis shows that the p.Ser633Trp mutation on the α-L-iduronidase affect significant the temporal and spatial properties of the different structural loops, the N-glycan attached to Asn372 and amino acid residues around the catalytic site of this enzyme. Low enzymatic activity observed for p.Ser633Trp variant of the α-L-iduronidase seems to lead to severe mucopolysaccharidosis type I phenotype, possibly associated with a perturbation of the structural dynamics in regions of the enzyme close to the active site.

Indexed as

Point MutationAbnormalities, MultipleCatalytic DomainCrystallography, X-RayDermatan SulfateEnzyme Replacement TherapyGene ExpressionHeparan SulfateHumansIduronidaseInfantMaleMolecular Dynamics SimulationMucopolysaccharidosis IPrincipal Component AnalysisProtein BindingDermatan SulfateHeparan SulfateIduronidaseAlpha-L-iduronidase mutationHurlerMucopolysaccharidosisStructural dynamics

Identifiers

PMID33389473
OpenAlexW3120795818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.